Genetic cancer screening can help you uncover a women’s hereditary health risk before you find a lump. 1 in 4 women in the general population meet criteria for hereditary cancer genetic testing.

Family history alone isn’t enough to determine a woman’s risk of cancer. Comprehensive risk assessment and genetic testing for all women helps you identify those who may need additional health care.

Nearly half of patients with a BRCA1 or BRCA2 genetic variant do not have a suggestive family history—but need additional care knowing their genetic status before a breast cancer diagnosis leads to improved survival rates. For those patients who test negative for pathogenic variants, Invitae can provide a Tyrer-Cuzick score, so you can get a more complete picture. The 5-year survival rate in patients who knew heir BRCA1/BRCA2 status before diagnosis is 94% compared with 78% in patients who only found out their status after diagnosis (P<0.03).